SSA
NVAX icon

Schonfeld Strategic Advisors’s Novavax NVAX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$732K Sell
89,913
-20,122
-18% -$182K 0.01% 1232
2025
Q4 		$739K Buy
110,035
+52,089
+90% +$393K ﹤0.01% 1247
2025
Q3 		$502K Buy
+57,946
New +$451K ﹤0.01% 1688
2025
Q1 		– Sell
-27,283
Closed -$219K – 2413
2024
Q4 		$219K Buy
27,283
+8,454
+45% +$81.5K ﹤0.01% 1736
2024
Q3 		$238K Sell
18,829
-4,072
-18% -$52.6K ﹤0.01% 1753
2024
Q2 		$290K Buy
+22,901
New +$230K ﹤0.01% 1700
2024
Q1 		– Sell
-10,395
Closed -$49.9K – 2292
2023
Q4 		$49.9K Sell
10,395
-73,346
-88% -$449K ﹤0.01% 1670
2023
Q3 		$606K Buy
+83,741
New +$669K ﹤0.01% 1157
2023
Q1 		– Sell
-44,500
Closed -$457K – 2468
2022
Q4 		$457K Sell
44,500
-158,959
-78% -$2.81M ﹤0.01% 1574
2022
Q3 		$3.7M Buy
203,459
+141,731
+230% +$6.14M 0.03% 633
2022
Q2 		$3.17M Buy
61,728
+34,546
+127% +$1.79M 0.03% 606
2022
Q1 		$2M Buy
27,182
+20,608
+313% +$1.84M 0.02% 739
2021
Q4 		$941K Buy
+6,574
New +$1.13M 0.01% 975
2021
Q3 		– Sell
-12,900
Closed -$2.74M – 2370
2021
Q2 		$2.74M Buy
+12,900
New +$2.36M 0.03% 618
2019
Q2 		– Sell
-985
Closed -$11K – 1175
2019
Q1 		$11K Sell
985
-22,040
-96% -$696K ﹤0.01% 1007
2018
Q4 		$847K Buy
+23,025
New +$892K 0.03% 516

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's NVAX Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its Novavax (NVAX) stake by 18% in Q1 2026, selling an estimated $182K and leaving 89,913 shares worth $732K. The position accounts for 0.01% of the portfolio, ranked #1232.

Schonfeld Strategic Advisors first reported a position in NVAX in Q4 2018 and has held it in 16 quarters since. The position peaked at $3.7M in Q3 2022. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Schonfeld Strategic Advisors held 89,913 shares of Novavax worth $732K as of Q1 2026.
  • Schonfeld Strategic Advisors sold 20,122 Novavax shares in Q1 2026, an estimated $182K.
  • Novavax made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1232 holding.
  • Schonfeld Strategic Advisors first reported a position in Novavax in Q4 2018 and has held it in 16 quarters since.
  • Schonfeld Strategic Advisors's Novavax position peaked at $3.7M in Q3 2022.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.